Skip to content
Recall Observatory FDA recall evidence

Drug product

Memantine Hydrochloride Extended-release Capsules, 28mg, packaged in 100-count Unit Dose Cartons , Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202 United States; Distributed by: Major Pharmaceuticals, 17177 N Laurel Park Dr., Suite 233, Livonia, MI 48152 USA, NDC 0904-6735-61

D-0844-2020

December 13, 2019

Class III

Product summary

Firm
The Harvard Drug Group
Event
Event 84955
Status
Terminated
Classification
Class III
Quantity
246 Cartons
Official record key
drug-enforcement:D-0844-2020

Official wording

Reason: Failed Dissolution Specifications: High out of specification result observed at stability studies.

Code information: Lot# M02465D

Distribution pattern: U.S.A. Nationwide

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    out of specification